Histogenetics

Histogen, Inc. is a regenerative medicine company developing innovative therapies based upon the products of cells grown under simulated embryonic conditions. Histogen has developed a rich product portfolio from one core technology process that fulfills market needs without containing embryonic stem cells or animal components.
The purpose and focus of the Company is on the research, development, and manufacturing of products derived from the Company's core technology. Histogen's proprietary technology process mimics the embryonic environment, including very low oxygen and suspension, encouraging newborn cells to naturally produce vital proteins and growth factors that are characteristic of young, rapidly developing tissue, and which can stimulate stem cells in the patient's own body to regenerate new tissue. Using this proprietary tissue-engineering platform, Histogen has created products that offer unique commercialization opportunities.